期刊
JOURNAL OF ALZHEIMERS DISEASE
卷 40, 期 3, 页码 687-700出版社
IOS PRESS
DOI: 10.3233/JAD-132345
关键词
Atrophy; biomarker; cholinergic system; dementia; European DTI Study on Dementia
资金
- Katharina-Hardt-Foundation, Bad Homburg, Germany
- Science Foundation Ireland through the Stokes Programme
- NIH [R01AG040311]
- NATIONAL INSTITUTE ON AGING [R01AG040311] Funding Source: NIH RePORTER
Histopathological studies in Alzheimer's disease (AD) suggest severe and region-specific neurodegeneration of the basal forebrain cholinergic system (BFCS). Here, we studied the between-center reliability and diagnostic accuracy of MRI-based BFCS volumetry in a large multicenter data set, including participants with prodromal (n = 41) or clinically manifest AD (n = 134) and 148 cognitively healthy controls. Atrophy was determined using voxel-based and region-of-interest based analyses of high-dimensionally normalized MRI scans using a newly created map of the BFCS based on postmortem in cranio MRI and histology. The AD group showed significant volume reductions of all subregions of the BFCS, which were most pronounced in the posterior nucleus basalis Meynert (NbM). The mild cognitive impairment-AD group showed pronounced volume reductions in the posterior NbM, but preserved volumes of anterior-medial regions. Diagnostic accuracy of posterior NbM volume was superior to hippocampus volume in both groups, despite higher multicenter variability of the BFCS measurements. The data of our study suggest that BFCS morphometry may provide an emerging biomarker in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据